Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
To study the possible involvement of reactive oxygen species (ROS) in the tumor biology of human renal‐cell carcinoma (RCC), we analvzed 35 cases of RCC for 2 parameters of oxidative damage: 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), a mutation‐prone DNA‐ base ‐modified product, was measured by means of high‐performance liquid chromatography (HPLC) with an electrochemical (EC) detector, and 4‐hydroxy‐2‐nonenal (HNE)‐modified proteins were measured with a poly‐clonal antibody against HNE‐modified proteins. A 54% higher content of 8‐OHdG was found in RCC than in the corresponding non‐tumorous kidney, suggesting that the DNA of RCC is more exposed to ROS than is the DNA of non‐tumorous kidneys. Immunohistochemistry for HNE‐modified proteins showed a distinct staining pattern of fine to coarse granularity in the cytoplasm of RCC (n = 15), implying that lipid peroxidation products are located in cytoplasmic organelles. These results suggest that RCC constitutionally elaborates more ROS than is produced by the non‐tumorous parts of kidneys. No correlation was found between clinical stage, histology, age or sex and the 2 parameters examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Toyokuni, S., Uchida, K., Okamoto, K., Hattori-Nakakuki, Y., Hiai, H., & Stadtman, E. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2616 · Cited by 331
Self-citation
Cited by
Oxidative DNA damage: mechanisms, mutation, and disease
Cooke, M. S., Evans, M. D., Dizdaroglu, M., & Lunec, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0752rev · Cited by 3,245
ROS stress in cancer cells and therapeutic implications
Pelicano, H., Carney, D., & Huang, P. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.004 · Cited by 2,006
The importance of glutathione in human disease
Townsend, D. M., Tew, K. D., & Tapiero, H. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00043-x · Cited by 2,004
Oxidative DNA damage and disease: induction, repair and significance
Evans, M. D., Dizdaroglu, M., & Cooke, M. S. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.11.001 · Cited by 1,372
Persistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Self-citation4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Self-citationKasai, H. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00035-5 · Cited by 1,139
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Self-citationCancer risk and oxidative DNA damage in man
Loft, S., & Poulsen, H. E. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00207507 · Cited by 945
Role of oxidative stress and DNA damage in human carcinogenesis
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.12.016 · Cited by 930
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH
Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 862
Role of reactive oxygen species in apoptosis: implications for cancer therapy
Matés, J. M., & Sánchez-Jiménez, F. M. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00088-6 · Cited by 771
Base excision repair of oxidative DNA damage and association with cancer and aging
Maynard, S., Schurman, S. H., Harboe, C., de Souza-Pinto, N. C., & Bohr, V. A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn250 · Cited by 680
Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation
Uchida, K., Shiraishi, M., Naito, Y., Torii, Y., Nakamura, Y., & Osawa, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2234 · Cited by 576
Self-citationReactive oxygen species‐induced molecular damage and its application in pathology
Toyokuni, S. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00829.x · Cited by 552
Self-citationAntioxidant enzymes and their implications in pathophysiologic processes
Mates, J. M. (1999) · Frontiers in Bioscience · doi:10.2741/a432 · Cited by 520
Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
Lee Mosley, R., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K., Laurie, C., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 387
Superoxide dismutases in malignant cells and human tumors
Kinnula, V. L., & Crapo, J. D. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.010 · Cited by 373
KARIHTALA, P., & SOINI, Y. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_514.x · Cited by 339
4-Hydroxy-2-nonenal-mediated Impairment of Intracellular Proteolysis during Oxidative Stress
Okada, K., Wangpoengtrakul, C., Osawa, T., Uchida, K., Toyokuni, S., & Tanaka, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23787 · Cited by 325
Self-citationCurrent Status of Acrolein as a Lipid Peroxidation Product
Uchida, K. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00016-x · Cited by 301
Self-citationBioavailability and metabolism
Stahl, W. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00016-x · Cited by 286
4-Hydroxy-2-nonenal: a critical target in oxidative stress?
Breitzig, M., Bhimineni, C., Lockey, R., & Kolliputi, N. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00101.2016 · Cited by 254
Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
“In other words, cancer cells can resist iron-induced oxidative stress through genetic alteration but still require more iron for proliferation and experience persistent oxidative stress, albeit at a low level [31,36,161,162].”
BackgroundSelf-citationToyokuni, S. (2016) · Pathology International · doi:10.1111/pin.12396 · Cited by 111
Self-citationOxidative Stress and Cancer: The Role of Redox Regulation
Toyokuni, S. (1998) · Biotherapy · doi:10.1023/a:1007934229968 · Cited by 69
Self-citationOxidative stress as an iceberg in carcinogenesis and cancer biology
Toyokuni, S. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.025 · Cited by 66
Self-citationLou, B., Boger, M., Bennewitz, K., Sticht, C., Kopf, S., Morgenstern, J., Fleming, T., Hell, R., Yuan, Z., Nawroth, P. P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101723 · Cited by 54
Metadata
- Authors
- Okamoto, K., Toyokuni, S., Uchida, K., Ogawa, O., Takenewa, J., Kakehi, Y., Kinoshita, H., Hattori‐Nakakuki, Y., Hiai, H., & Yoshida, O.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-09-15
- Volume
- 58
- Issue
- 6
- Pages
- 825-829
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2012637140
- Cited by
- 179
- References
- 2
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.